Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Cases · March 25, 2019

Young Patient With Weak ER Positive PR Negative and HER2 Negative Breast Cancer

aisha alharbi

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Levon Badalyan

    Mar 29, 2019

    I would treat her as Tiple Negative adding Carboplatin to Taxane even regardless BRCA. usually we treat aggressive phenotypes Neoadjuvantly, to obtain tumor response. I would not recomment pregnancy in the near 5 years.

  • sehrish sarwar

    Mar 31, 2019

    It would be appropriate to treat her as triple negative and incorporate platinums with taxane. Moreover if she wants to get pregnant we can continue her on tamoxifen and zoladex for 2 years and then discontinue it and give her the time to get preganent after 6 months of discontinuation of hormonal treatment. 

  • Khalid Akhtar

    Apr 01, 2019

    Yes she can be treated, triple negative Breast Cancer employing Platinum with taxanes. She can have three years of tamoxifen & Zoladex late. For future pregnancy if she remains recurrence free then stop hormonal treatment and can have pregnancy.

  • Dr.kawyba A.A.A

    Apr 01, 2019

    Thanks 
    Would recommend dose dense or q3 weeks? 

  • ARVIND KUMAR

    May 08, 2019

    Dose dense therapy 

  • Apr 18, 2024

    Pending Moderator approval.
    Delete

Further Reading